Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk bolsters management team

Appoints Camilla Sylvest and Doug Langa

Camilla SylvestDanish pharmaceutical company Novo Nordisk has appointed Camilla Sylvest (pictured right) as its executive vice president in charge of commercial strategy and corporate affairs.

At the helm of this new unit she will be responsible for the company’s corporate functions within marketing, market access, strategy, communications, stakeholder relations and sustainability.

Prior to her new role, Sylvest was the company’s senior vice president in charge of its Chinese operations since 2015.

Lars Fruergaard Jørgensen, president and CEO at Novo Nordisk, said: “During her more than 20 years in Novo Nordisk, Camilla has consistently delivered strong business results, fostered strong relations with stakeholders and demonstrated a natural ability to rally her organisations around key priorities.

“This makes me very confident in her ability to successfully drive our commercial strategies as well as our strategies Doug Langafor developing Novo Nordisk as a responsible corporation focused on the needs of the patients we serve.”

Additionally, Doug Langa (pictured left), senior vice president, head of North America operations and president of Novo Nordisk Inc, is promoted to executive vice president.

He joined the company in 2011 and has over 25 years’ experience in the pharmaceutical and medical device industry.

Both Sylvest and Langa will report to Jørgensen.

17th August 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....